Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, United Kingdom.
Medical School, University College London, London, United Kingdom.
Neuroendocrinology. 2019;109(2):179-186. doi: 10.1159/000499381. Epub 2019 May 6.
Appendiceal neuroendocrine neoplasms (ANEN) are uncommon entities, which run mostly an indolent course. Appendicectomy alone is usually curative, except for in a selected group of patients that are deemed to be at risk of loco-regional metastases, in whom a completion right hemicolectomy (RHC) is recommended. The current "Guidelines" criteria for the latter have been controversial, and may result in overtreatment, which is concerning for a young patient population.
The aim of this study is to evaluate the prognostic value of the current criteria in identifying more accurately those at-risk patients.
This was a retrospective study of the 263 cases of ANEN referred for advice or management to a tertiary referral unit over a 10-year period. Seventy-two patients underwent RHC, based on criteria, suggested by International Guidelines. Each one of those was assessed to identify whether it correlated with lymph node invasion (LNI) at the RHC surgical specimen.
Tumour grade (p < 0.001), vascular (p = 0.044) and lymph vessel invasion (p < 0.001) were all found to be statistically significant independent risk factors for LNI identified following RHC, whilst tumour size (p = 0.375) and mesoappendiceal invasion (MAI) (p = 0.317) were not statistically significant. However, deep MAI and tumour size >2 cm showed a correlation with each other on LNI positive subgroup analysis. Location in appendiceal base made LNI more likely but again was not significant (p = 0.133).
Higher tumour grade and lymphovascular invasion should be considered as the most important risk prognosticators. Surprisingly, tumour size was not found to be significant in our cohort. Further international multicentre studies with large numbers of patients are needed to fully validate those data.
阑尾神经内分泌肿瘤(ANEN)较为少见,其病程大多较为缓慢。单纯行阑尾切除术通常可以达到治愈效果,除非患者被认为存在局部转移的风险,此时建议行右半结肠切除术(RHC)。目前,对于这种情况的“指南”标准存在争议,可能导致过度治疗,这对于年轻患者群体来说是令人担忧的。
本研究旨在评估当前标准在更准确识别高危患者方面的预后价值。
这是一项回顾性研究,纳入了在 10 年内转诊至三级转诊单位的 263 例 ANEN 患者。根据国际指南建议的标准,72 例患者接受了 RHC。对每例患者进行评估,以确定其是否与 RHC 手术标本中的淋巴结侵犯(LNI)相关。
肿瘤分级(p<0.001)、血管侵犯(p=0.044)和淋巴管侵犯(p<0.001)均被发现是与 RHC 后 LNI 相关的统计学显著独立危险因素,而肿瘤大小(p=0.375)和系膜侵犯(p=0.317)则不是统计学显著危险因素。然而,深部系膜侵犯和肿瘤大小>2cm 在 LNI 阳性亚组分析中存在相关性。阑尾根部位置使 LNI 更有可能发生,但也无统计学意义(p=0.133)。
较高的肿瘤分级和淋巴管侵犯应被视为最重要的预后预测因素。令人惊讶的是,在我们的队列中,肿瘤大小并未被发现具有显著意义。需要进行更多的国际多中心研究,纳入大量患者,以充分验证这些数据。